Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Current Assets (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Current Assets for 16 consecutive years, with $78.3 million as the latest value for Q3 2025.

  • Quarterly Current Assets rose 9.69% to $78.3 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $78.3 million through Sep 2025, up 9.69% year-over-year, with the annual reading at $67.1 million for FY2024, 3.46% up from the prior year.
  • Current Assets for Q3 2025 was $78.3 million at Xtant Medical Holdings, up from $75.6 million in the prior quarter.
  • The five-year high for Current Assets was $78.3 million in Q3 2025, with the low at $36.6 million in Q1 2023.
  • Average Current Assets over 5 years is $56.3 million, with a median of $49.4 million recorded in 2021.
  • The sharpest move saw Current Assets dropped 14.44% in 2023, then soared 81.87% in 2024.
  • Over 5 years, Current Assets stood at $44.3 million in 2021, then rose by 11.25% to $49.3 million in 2022, then surged by 31.53% to $64.9 million in 2023, then increased by 3.46% to $67.1 million in 2024, then rose by 16.71% to $78.3 million in 2025.
  • According to Business Quant data, Current Assets over the past three periods came in at $78.3 million, $75.6 million, and $69.1 million for Q3 2025, Q2 2025, and Q1 2025 respectively.